Proteros biostructures Expands Successful Protein Crystallography Collaboration With OSI Pharmaceuticals
Proteros biostructures GmbH ('Proteros') announced recently the expansion of its collaboration with OSI Pharmaceuticals, Inc. ('OSI') in the field of protein crystallography. Following the successful delivery of valuable high resolution protein-ligand-structures on multiple kinase targets under Proteros' Gallery Structure mode with compounds supplied by OSI, Proteros will now provide also Gene-to-Structure services to OSI.
This Gene-to-Structure agreement marks the fifth project under the master service agreement signed in October 2007. Under it Proteros will utilize its capabilities in construct design, protein expression and purification as well as protein structure determination to deliver a de novo protein structure and several protein-ligand-structures on a challenging kinase target to OSI.
Dr. Torsten Neuefeind, Proteros' Chief Executive Officer, commented, "The successes so far demonstrate that the combination of Proteros' industrial approach, unique technologies and expertise can quickly generate valuable structural data to meet the highest quality standards required by OSI. We look forward to continuing to demonstrate the value of this collaboration and contributing to accelerating drug discovery programmes at OSI."
About Proteros biostructures GmbH:
Proteros biostructures is a privately held company, which provides full services and unique technologies for X-ray protein structure analysis to the life science industries. The company accelerates and improves structure analysis and structure-based drug discovery by its expertise, industrialized process and unique technologies, e.g. Free Mounting System and Picodropper, enabling time and cost-efficient protein-ligand-structure analyses. Proteros complements its clients' internal capabilities with its external expertise and access to flexible resources. Proteros currently provides services to over forty pharmaceutical and biotechnology companies in North America, Europe and Japan. More information about Proteros can be found on the company's website at www.proteros.com.
SOURCE: Proteros biostructures GmbH